Europe Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product; Functionality; Type of Formulation

Fillers and Diluents Segment has the Largest Share of Product in the Europe Pharmaceutical Excipients Market during 2020-2027





According to this research study titled “Europe Pharmaceutical Excipients Market to 2027 - COVID-19 Impact and Regional Analysis and Forecast by Product, Functionality, and Type of Formulation,” the market is expected to reach US$ 3,796.4 million by 2027 from US$ 2,560.5 million in 2019. The market is estimated to grow at a CAGR of 5.2% from 2020 to 2027. The report provides trends prevailing in the Europe Pharmaceutical excipients market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the surge in generics market and growth of the pharmaceutical market backed by multi-functional excipients are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the cost and time intensive drug development process.

Critical drugs can be added to the list in due course as further clinical policies are developed to support the COVID-19 response. Likely, any medicine containing a new active substance for the treatment of viral diseases falls within the mandatory scope of the centralized procedure, meaning that they must be assessed by the European Medicines Agency (EMA) and authorized by the European Commission. EMA is ready to support medicine developers with all available regulatory tools to advance and expedite the development of effective measures to fight and prevent the spread of this virus. These include fast tracked scientific advice, PRIME scheme, accelerated assessments and conditional marketing authorizations. Furthermore, growing research activities to develop treatment against corona virus is likely to favor the growth of the market. As Europe has been impacted by the COVID-19 pandemic, an extensive clinical research is currently being conducted to identify effective therapies. The UK dominates the COVID-19 research space, and accounts for the largest number of clinical trials (24.5%), which is then followed by Spain (13.2%), France (9.5%), Italy (5.3%), Russia (4.8%), and Germany (3.8%).

The market for pharmaceutical excipients market is segmented into product, functionality, and type of formulation. Based on product, the pharmaceutical excipients market is segmented into organic chemicals, inorganic chemicals and other products. In 2019, the organic chemicals segment accounted for the largest share, moreover the same segment is expected to grow at a fastest CAGR during the forecast period. Organic chemicals are chemical compounds that contain carbon-hydrogen bonds and these can be found in natural or synthetic form. Most organic chemicals are carbon based, hence produced by plants or animals, whereas synthetic organic chemicals are produced through chemical reactions. Organically derived pharmaceuticals excipients include oleochemicals, carbohydrates, petrochemicals, proteins, povidones, acrylic polymers, mineral hydrocarbons, starch, cellulose, and others. The most commonly used oleo chemical-based pharmaceutical excipients are fatty alcohols, mineral stearates, glycerin, and lipids. The organic segment is expected to lead the market owing to the rise in the use of organic chemicals in various formulations in the pharmaceutical industry.

DuPont de Nemours, Inc., Roquette Frères, Ashland Global Holdings, Inc., BASF SE, Evonik Industries AG, Associated British Foods Plc, Archer Daniels Midland Company, Lubrizol Corporation, DFE Pharma, and Croda International Plc are among the leading companies in the Europe pharmaceutical excipients market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in April 2020, a new portfolio of excipients is launched by DFE Pharma which aids in stabilizing biologics. Samples of Trehalose and Sucrose, the first in this BioHale range, are now available and can be ordered online. Recent developments in the field of biologics provide unique therapy options for many of the world’s most challenging diseases. Therapeutic protein solutions play an increasingly important role in the pipelines of pharmaceutical companies. The significance of biologics has remarkably grown in past years and it is foreseen that this growth will even further continue in near future.

The report segments the Europe Pharmaceutical Excipients market as follows:

By Product

• Organic Chemicals
• Inorganic Chemicals
• Other Products

By Functionality

• Fillers & Diluents
• Suspending & Viscosity Agents
• Coating Agents
• Binders
• Preservatives
• Emulsifying Agents
• Other Functionalities

By Type of Formulation

• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other Formulations

By Country

• Europe - Germany
• UK
• France
• Spain
• Italy
• Rest of Europe